The optimal cutoff values of PCT and PSS for predicting AKI in patients with COVID-19 were 2.26 ng/mL (sensitivity, 64.3%; specificity, 89.5%) and 572 pg/mL (sensitivity, 66.0%; specificity, 69.1%), respectively. This evidence concerns the gene CALCA and acute kidney injury.